NMPA Approval

Recombinant Staphylokinase for Injection(r-Sak)

Approval Number

国药准字S20060080

Company成都地奥九泓制药厂

Registration Date

May 19, 2022

Previous Approval Numbers

国药准字S20060080

Drug Information

Generic Name

注射用重组葡激酶

Trade Name

依立通

Dosage Form

注射剂

Strength

5mg(25万单位)/瓶

Drug Type

生物制品

Registration Date

May 19, 2022

Company Information

Applicant Company

Company Name成都地奥九泓制药厂

Company Address

成都高新区高朋东路16号

Manufacturing Company

Company Name成都地奥九泓制药厂

Company Address

四川省成都市高新区高朋东路16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用重组葡激酶 - NMPA 批准文号 | MedPath